首页> 外文期刊>Respirology : >ICU ICU mortality is increased with high admission serum osmolarity in all patients other than those admitted with pulmonary diseases and hypoxia
【24h】

ICU ICU mortality is increased with high admission serum osmolarity in all patients other than those admitted with pulmonary diseases and hypoxia

机译:ICU ICU死亡率随着除肺病和缺氧而入院的所有患者中的高入院血清渗透性增加

获取原文
获取原文并翻译 | 示例
           

摘要

ABSTRACT Background and objective High serum osmolarity has been shown to be lung protective. There is lack of clinical studies evaluating the impact on outcomes such as mortality. We aimed to examine the effect of serum osmolarity on intensive care unit ( ICU ) mortality in critically ill patients Methods Data from January 2000 to December 2012 was accessed using the Australian and New Zealand Intensive Care Society ( ANZICS ) Clinical Outcomes and Resource Evaluation ( CORE ) database. A total of 509?180 patients were included. Serum osmolarity was calculated from data during the first 24?h of ICU admission. Predefined subgroups (Acute Physiology and Chronic Health Evaluation ( APACHE ) III diagnostic codes), including patients with acute pulmonary diagnoses, were examined. The effect of serum osmolarity on ICU mortality was assessed with analysis adjusted for illness severity (serum sodium, glucose and urea component removed) and year of admission. Results are presented as OR (95% CI ) referenced against a serum osmolarity of 290–295?mmol/L. Results The ICU mortality was elevated at each extremes of serum osmolarity (U‐shaped relationship). A similar relationship was found in various subgroups, with the exception of patients with pulmonary diagnoses in whom ICU mortality was not influenced by high serum osmolarity and was different from other non‐pulmonary subgroups ( P ??0.01). Any adverse associations with high serum osmolarity in pulmonary patients were confined to patients with a PaO 2 / FiO 2 ratio??200. Conclusion High admission serum osmolarity was not associated with increased odds for ICU death in pulmonary patients, unlike other subgroup of patients, and could be a potential area for future interventional therapy.
机译:摘要背景和客观高血清渗透压已被证明是肺保护。缺乏临床研究评估对死亡率等结果的影响。我们旨在研究血清渗透性对重症监护单位(ICU)的影响,在批判性病患者方法中,从2012年1月到2012年1月的数据使用澳大利亚和新西兰重症监护社会(ANZICS)临床结果和资源评估(核心)数据库。共有509例患者。血清渗透性由ICU入学的第24次H的数据计算。检查预定义的亚组(急性生理学和慢性健康评估(Apache)III诊断码),包括急性肺诊断患者。评估血清渗透性对ICU死亡率的影响,分析调整为疾病严重程度(血清钠,葡萄糖和尿素成分)和入院年份。结果呈现为或(95%CI),其血清渗透压为290-295摩尔/升。结果ICU死亡率在血清渗透压(U形关系)的每个极端处升高。在各种亚组中发现了类似的关系,除了肺部诊断的患者外,ICU死亡率不会受到高血清渗透性的影响,并且与其他非肺部亚组不同(p≤0.01)。肺患者中具有高血清渗透压血清渗透性的任何不良关联被局限于PAO 2 / FIO 2比率的患者。&?200。结论肺病患者的ICU死亡率增加,高入院血清渗透性与ICU死亡的增加无关,不同于患者的其他亚组,可能是未来介入治疗的潜在区域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号